Capsid Proteins
These proteins play a crucial role in viral assembly, stability, and host cell recognition.
Undestand the latest research on Capsid Proteins with PubCompare.ai's AI-driven optimization.
Discover the most effective protocols from scientific literature, preprints, and patents.
Leverage cutting-edge AI to identify the best products and procedures for your Capsid Protein research.
Experiene the power of PubCompare.ai's innovative technology today.
Most cited protocols related to «Capsid Proteins»
PASTEC classifies TEs by testing all classifications from Wicker's hierarchical TE classification system. Each possible classification is weighted according to the available evidence, with respect to the classification considered. TEs are currently classified to class and order level. PASTEC can also determine whether a TE is complete on the basis of four criteria: sequence coverage for known TEs, profile coverage, presence of terminal repeats for certain classes, presence of a polyA or SSR tail for LINEs and SINEs, and the length of the TEs with respect to expectations for the class concerned.
We designed PASTEC as a modular multi-agent classifier. The system is composed of four types of agents: retrievers, classifiers, filter agents, and a super-agent (
The output can be read by humans and is biologist-friendly. A single line specifies the name of the TE, its length, status, class, order, completeness, confidence index and all the features characterizing it. A status of “potential chimeric” or “OK” is assigned to the TE. If the TE is not considered to be “OK” then users must apply their own expertise. A TE is declared “potential chimeric” when at least two classifications are possible. In this case, PASTEC chooses the best status based on the available evidence, or does not classify the TE if no decision is possible. In this last case, all possible classifications are given (separated by a pipe symbol “|”). We present an example of PASTEC output in
The largest DTR contig we identified from IMG/VR was further annotated to illustrate the type of virus and genome organization represented (IMG ID: 3300025697_____Ga0208769_1000001). Coding sequence prediction and functional annotations were obtained from IMG35 (link). Annotation for virus hallmark genes including a terminase large subunit (TerL) and major capsid protein were confirmed via HHPred v.3.2.0 (ref. 62 (link)) (databases included PDB 70_8, SCOPe70 2.07, Pfam-A 32.0 and CDD 3.18, score >98). A circular genome map was drawn with CGView63 (link). To place this contig in an evolutionary context, we built a TerL phylogeny including the most closely related sequences from a global search for large phages42 (link). The TerL amino acid sequence from the DTR contig was compared to all TerL sequences from the ‘huge phage’ dataset via blastp (≤1 × 10–5, score ≥50) to identify the 30 most similar sequences (sorted based on blastp bit-score). These reference sequences and DTR contigs were aligned with MAFFT v.7.407 (ref. 64 (link)) using default parameters, the alignment automatically cleaned with trimAL v.1.4.rev15 with the option ‘--gappyout’65 (link) and a phylogeny built with IQ-Tree v.1.5.5, with default model selection (optimal model suggested: LG+R4)66 (link). The resulting tree was visualized with iToL67 (link).
Most recents protocols related to «Capsid Proteins»
Example 5
To deliver the albumin-specific ZFNs to the liver in vivo, the normal site of albumin production, we generated a hepatotropic adeno-associated virus vector, serotype 8 expressing the albumin-specific ZFNs from a liver-specific enhancer and promoter (Shen et al., ibid and Miao et al., ibid). Adult C57BL/6 mice were subjected to genome editing at the albumin gene as follows: adult mice were treated by i.v. (intravenous) injection with 1×1011 v.g. (viral genomes)/mouse of either ZFN pair 1 (SBS 30724 and SBS 30725), or ZFN pair 2 (SBS 30872 and SBS 30873) and sacrificed seven days later. The region of the albumin gene encompassing the target site for pair 1 was amplified by PCR for the Cel-I mismatch assay using the following 2 PCR primers:
The region of the albumin gene encompassing the target site for pair 2 was amplified by PCR for the Cel-I assay using these PCR primers:
As shown in
The mouse albumin specific ZFNs SBS30724 and SBS30725 which target a sequence in intron 1 were also tested in a second study. Genes for expressing the ZFNs were introduced into an AAV2/8 vector as described previously (Li et al. (2011) Nature 475 (7355): 217). To facilitate AAV production in the baculovirus system, a baculovirus containing a chimeric serotype 8.2 capsid gene was used. Serotype 8.2 capsid differs from serotype 8 capsid in that the phopholipase A2 domain in capsid protein VP1 of AAV8 has been replaced by the comparable domain from the AAV2 capsid creating a chimeric capsid. Production of the ZFN containing virus particles was done either by preparation using a HEK293 system or a baculovirus system using standard methods in the art (See Li et al., ibid, see e.g., U.S. Pat. No. 6,723,551). The virus particles were then administered to normal male mice (n=6) using a single dose of 200 microliter of 1.0el 1 total vector genomes of either AAV2/8 or AAV2/8.2 encoding the mouse albumin-specific ZFN. 14 days post administration of rAAV vectors, mice were sacrificed, livers harvested and processed for DNA or total proteins using standard methods known in the art. Detection of AAV vector genome copies was performed by quantitative PCR. Briefly, qPCR primers were made specific to the bGHpA sequences within the AAV as follows:
Cleavage activity of the ZFN was measured using a Cel-I assay performed using a LC-GX apparatus (Perkin Elmer), according to manufacturer's protocol. Expression of the ZFNs in vivo was measured using a FLAG-Tag system according to standard methods.
As shown in
The mouse specific albumin ZFNs were also tested for in vivo activity when delivered via use of a variety of AAV serotypes including AAV2/5, AAV2/6, AAV2/8 and AAV2/8.2. In these AAV vectors, all the ZFN encoding sequence is flanked by the AAV2 ITRs, contain, and then encapsulated using capsid proteins from AAV5, 6, or 8, respectively. The 8.2 designation is the same as described above. The SBS30724 and SBS30725 ZFNs were cloned into the AAV as described previously (Li et al., ibid), and the viral particles were produced either using baculovirus or a HEK293 transient transfection purification as described above. Dosing was done in normal mice in a volume of 200 μL per mouse via tail injection, at doses from 5e10 to 1e12 vg per dose. Viral genomes per diploid mouse genome were analyzed at days 14, and are analyzed at days 30 and 60. In addition, ZFN directed cleavage of the albumin locus was analyzed by Cel-I assay as described previously at day 14 and is analyzed at days 30 and 60.
As shown in
experiments were subjected to enzymatic pretreatment to digest gRNA
not protected by an intact viral capsid. Two-hundred and fifty microliters
of the sample was treated with 0.1 U/μL of RNase I (Thermo Fisher)
with a 30 min (20-2) or 15 min (15-2) incubation period at 37 °C,
and RNA extractions immediately followed the incubation period. The
validity of this method was tested using creek water inoculated with
intact HuNoV and naked gRNA.
of HuNoV, as well as the signal decay of the intact viral capsid and
RNA genome in creek water (15-1, 15-2, 20-1, and 20-2;
GII.4 Sydney strain such that the starting concentration was between
2.4 × 105 ± 4.3 × 104 and 7.1
× 105 ± 3.5 × 104 gene copies
per mL (gc/mL) of HuNoV (error is the standard deviation). Water samples
were aseptically divided into 1 mL aliquots and stored in the dark
at 15 °C (15-1 and 15-2) or 20 °C (20-1 and 20-2). One 1
mL aliquot was sacrificed at each time point (
and the duration of the experiments was 5 and 28 days. Experiments
20-1 and 20-2 were each completed with replicate 1 mL aliquots at
each time point (
point, each sacrificed aliquot was divided into two: one subaliquot
was used to evaluate HuNoV infectivity in HIE cells and the other
to evaluate HuNoV decay using five different RT-qPCR assays. Additional
details can be found in the
The
concentrations of one short segment of gRNA commonly used to quantify
HuNoV in the environment (89 nt, hereafter referred to as “ORF”),
and four different long segments (∼500 nt) of gRNA were measured
at each time point using RT-qPCR. The combined damage incurred by
the long genome segments was extrapolated to estimate that of the
whole genome.31 (link) For the short-genome segment
dsDNA assay, the R2 and efficiency of
the master standard curve were 0.99 and 84.3%, respectively (
assays used on experimental samples, the R2 and efficiency of the master standard curves ranged from 0.93 to
1 and 76.6 to 100.1%, respectively (
samples pretreated with RNase I (Thermo Fisher Scientific; enzyme-treated
RT-qPCR; ET-RT-qPCR) to eliminate gRNA not protected within an intact
viral capsid.42 (link)−44 (link) The details of these methods are provided below.
Positive HuNoV stool samples were limited and so different HuNoV
stool filtrates were used for experiments 15-1 and 15-2 (accession
#MK764019) and experiments 20-1 and 20-2 (accession #OL913976). Although
the genomic sequences of these HuNoV strains have 97.7% pairwise nucleotide
identity and were genotyped as GII.4 Sydney, separate RT-qPCR assays
targeting long segments of each genome had to be designed for use
with each (see details below).
Top products related to «Capsid Proteins»
More about "Capsid Proteins"
These crucial proteins play a vital role in viral assembly, stability, and host cell recognition.
Researching capsid proteins is essential for understanding virus biology and developing effective antiviral strategies.
To optimize your capsid protein research, you can leverage PubCompare.ai's AI-driven protocol optimization.
This innovative technology allows you to discover the most effective protocols from scientific literature, preprints, and patents.
By using intelligent comparisons, you can identify the best products and procedures for your capsid protein studies.
For example, you might utilize Lipofectamine 2000 for transfection, the QIAamp Viral RNA Mini Kit for viral RNA extraction, and TRIzol reagent for RNA isolation.
Benzonase can be used to remove unwanted nucleic acids, while the QIAquick PCR Purification Kit can be employed to purify your target DNA or RNA.
Additionally, fetal bovine serum (FBS) may be used to culture cells, and the RNeasy Mini Kit or DNeasy Blood and Tissue Kit can be utilized for RNA or DNA extraction, respectively.
When analyzing your samples, you can leverage nitrocellulose membranes for Western blotting and the SW41 rotor for ultracentrifugation.
By combining these cutting-edge tools with PubCompare.ai's AI-driven optimization, you can enhance the accuracy and efficiency of your capsid protein research, leading to groundbreaking discoveries.
Experience the power of PubCompare.ai's innovative technology today and take your capsid protein studies to new heights.